# Sodium Selenite Supplementation in Patients With Head and Neck Cancer

> **NCT05451576** · NA · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Selenium
- Sodium Selenite

## Interventions

- **DIETARY_SUPPLEMENT:** Zelnite®
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05451576
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-12
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05451576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05451576, "Sodium Selenite Supplementation in Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05451576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*